Status:
COMPLETED
PEG Solution (Laxabon®) 4L Versus Senna Glycoside (Pursennid® Ex-Lax) 36mg and PEG Solution (Laxabon®) 2L for Large Bowel Cleansing Prior to Colonoscopy
Lead Sponsor:
Umeå University
Conditions:
Colonoscopy
Eligibility:
All Genders
18+ years
Phase:
PHASE2
PHASE3
Brief Summary
The trial compares Laxabon® 4L versus Pursennid® Ex-Lax 36mg and 2L Laxabon® for large bowel cleansing prior to colonoscopy allocating patients planned for colonoscopy to one of the two cleansing regi...
Detailed Description
Effective large bowel cleansing prior to colonoscopy is still not achieved in all cases that undergo the procedure. The use of balanced electrolyte-polyethylene glycol (PEG) solution have improved the...
Eligibility Criteria
Inclusion
- Patient scheduled to undergo elective complete colonoscopy as an outpatient
- Age 18 or older
- The patient gives written informed consent and can understand the information given
- The patient can participate only once in the study
Exclusion
- Earlier resection of the large bowel or rectum
- Active known colitis
- Ileus or gastro-intestinal obstruction
Key Trial Info
Start Date :
September 1 2005
Trial Type :
INTERVENTIONAL
End Date :
December 1 2006
Estimated Enrollment :
490 Patients enrolled
Trial Details
Trial ID
NCT00390598
Start Date
September 1 2005
End Date
December 1 2006
Last Update
March 24 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Surgery, Umeå University Hospital
Umeå, Sweden, SE 90185